HOME >> BIOLOGY >> NEWS
Could diabetes treatments fight cancer?

Drugs that treat diabetes may also be effective against some cancers. In today's Journal of Biology, researchers at the University of Dundee report the discovery of an unexpected link between diabetes and Peutz-Jeghers syndrome, a hereditary disease that increases the risk of suffering from cancer.

The Dundee team were looking for a protein that activates AMPK, an enzyme that reduces blood glucose levels and is a target for drugs commonly used in treating Type 2 diabetes.

They hoped that this protein would be a target for new anti-diabetes drugs, and their search ended with an enzyme called LKB1. Surprisingly, a lack of LKB1 is a known cause of Peutz-Jeghers syndrome, in which the risk of developing some cancers is 15 times higher than normal.

"It was totally unexpected," said Dario Alessi, one of the research team leaders. "LKB1 was thought of as a tumour suppressor gene, and AMPK was involved in diabetes. No one thought that there could be a link between the two."

Grahame Hardie, the second team leader, said: "The idea that LKB1 might switch on AMPK came from work I did on a related system in the simple single-cell organism brewer's yeast. [] The idea that LKB1 might be the key was a genuine 'Eureka' moment, especially when I realised that Dario Alessi already worked on it and had all of the expertise necessary to test the idea."

Having identified the LKB1 enzyme in yeast, the Dundee team looked for its counterpart in rat liver extracts that could activate AMPK. They not only identified the rat version of LKB1, but also found two proteins that bind to LKB1 and enhance its activity. When the researchers removed LKB1 from the extract, they found that the extract could no longer activate AMPK, consistent with LKB1 being the activating enzyme.

LKB1 normally acts to prevent tumour growth. The way that it does this was unclear until now, but this research suggests that its tumour-preventing properties may be dependent o
'"/>

Contact: Gemma Bradley
press@biomedcentral.com
44-207-323-0323
BioMed Central
24-Sep-2003


Page: 1 2

Related biology news :

1. Endometriosis: Could angiostatic therapy be the new treatment of the future?
2. Could mice hold the secret to longer life?
3. Could vitamins raise levels of bad cholesterol? Animal study suggests they might
4. Could memory performance and spatial learning be genetically based?
5. Could a specific protein contribute to erectile dysfunction for the diabetic and obese?
6. Could rice be the source for a natural herbicide?
7. Could hibernators hold the key to improving organ preservation?
8. Could Bt transgenic crops have nutritionally favourable effects on insects?
9. Could one less cookie a day help the fight against fat?
10. Could an anti-marijuana compound hold the key to body weight and appetite control?
11. Study finds genetic aberrations linked to lung cancer; Could help in early diagnosis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/11/2020)... ... June 09, 2020 , ... Superior Controls, Inc. ... automation and IT solutions for the life sciences industry, is pleased to announce the ... working out of the company’s Seabrook, New Hampshire office. In his new role, ...
(Date:5/30/2020)... ... 29, 2020 , ... eInfochips, a leading provider of product ... EchoNous Inc. to develop the cloud-based connected health KOSMOS platform that has been ... been clinically tested versus expert measurements, yielding improved results in precision and consistency. ...
(Date:5/26/2020)... ... May 26, 2020 , ... ... solutions for biopharmaceutical R&D, today announced that Gritstone Oncology, Inc., a clinical-stage ... bispecific T cell engagers and TCR-based therapeutics, has implemented Genedata Biologics ...
Breaking Biology News(10 mins):
(Date:6/11/2020)... ... June 09, 2020 , ... PathSensors Inc., a Baltimore biotechnology ... Research (SBIR) program funded by the National Institute of Food and Agriculture (NIFA) ... The project’s goal was to engineer and develop a field-deployable instrument for portable ...
(Date:5/30/2020)... ... May 29, 2020 , ... Medrio, Inc., the leading provider ... has enabled Cytovale, Inc., a medical technology company dedicated to revolutionizing diagnostics for ... first patient in (FPI) in just seven days. The Cytovale technology will allow ...
(Date:5/21/2020)... ... May 21, 2020 , ... Threats to intellectual property, political ... Contrary to conventional wisdom that says the coronavirus pandemic will generally benefit biopharmaceutical ... from the pandemic commercially weaker, dealing with delays in new product launches and ...
(Date:5/15/2020)... ... May 14, 2020 , ... Children with ... heart surgeries before becoming adults. The reason: there are no heart valve ... unmet need, the Department of Defense has awarded Draper, Boston Children’s Hospital and ...
Breaking Biology Technology:
Cached News: